In This Article:
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Some large-cap stocks are past their peak, and StockStory is here to help you separate the winners from the laggards. That said, here are three S&P 500 stocks to avoid and some better alternatives instead.
Microchip Technology (MCHP)
Market Cap: $31.31 billion
Spun out from General Instrument in 1987, Microchip Technology (NASDAQ: MCHP) is a leading provider of microcontrollers and integrated circuits used mainly in the automotive world, especially in electric vehicles and their charging devices.
Why Should You Dump MCHP?
-
Customers postponed purchases of its products and services this cycle as its revenue declined by 3.6% annually over the last five years
-
Operating profits fell over the last five years as its sales dropped and it struggled to adjust its fixed costs
-
Free cash flow margin dropped by 16 percentage points over the last five years, implying the company became more capital intensive as competition picked up
At $57.80 per share, Microchip Technology trades at 51.4x forward P/E. If you’re considering MCHP for your portfolio, see our FREE research report to learn more.
News Corp (NWSA)
Market Cap: $16.82 billion
Established in 2013 after a restructuring, News Corp (NASDAQ:NWSA) is a multinational conglomerate known for its news publishing, broadcasting, digital media, and book publishing.
Why Are We Out on NWSA?
-
Products and services aren't resonating with the market as its revenue declined by 2.5% annually over the last five years
-
Projected sales growth of 2.5% for the next 12 months suggests sluggish demand
-
ROIC of 6.3% reflects management’s challenges in identifying attractive investment opportunities
News Corp’s stock price of $28.29 implies a valuation ratio of 31.6x forward P/E. Check out our free in-depth research report to learn more about why NWSA doesn’t pass our bar.
Hologic (HOLX)
Market Cap: $13.85 billion
As a pioneer in 3D mammography technology that has revolutionized breast cancer detection, Hologic (NASDAQ:HOLX) develops and manufactures diagnostic products, medical imaging systems, and surgical devices focused primarily on women's health and wellness.
Why Are We Cautious About HOLX?
-
Constant currency revenue growth has disappointed over the past two years and shows demand was soft
-
Costs have risen faster than its revenue over the last five years, causing its adjusted operating margin to decline by 23.2 percentage points
-
Waning returns on capital imply its previous profit engines are losing steam